Hydroxysafflor Yellow A modulation of metabolite networks and inhibition of JAK2/STAT1 pathway in sepsis

Abstract Sepsis, a severe infectious disease causing multiple organ dysfunction, requires further exploration of its pathomechanisms and therapeutic options. Hydroxysafflor Yellow A (HYSA), extracted from Carthamus tinctorius L, has shown anti-inflammatory and antioxidant properties effective in tre...

Full description

Saved in:
Bibliographic Details
Main Authors: Bingbing Pan, Fengting Chen, Siyan Shen, Yu Jiang, Ying Yang, Jia Wang, Yanjuan Liu, Lai Wei, Jitong Liu, Gaoyin Kong, Xuan He, Bing Guo
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-11545-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849332638219763712
author Bingbing Pan
Fengting Chen
Siyan Shen
Yu Jiang
Ying Yang
Jia Wang
Yanjuan Liu
Lai Wei
Jitong Liu
Gaoyin Kong
Xuan He
Bing Guo
author_facet Bingbing Pan
Fengting Chen
Siyan Shen
Yu Jiang
Ying Yang
Jia Wang
Yanjuan Liu
Lai Wei
Jitong Liu
Gaoyin Kong
Xuan He
Bing Guo
author_sort Bingbing Pan
collection DOAJ
description Abstract Sepsis, a severe infectious disease causing multiple organ dysfunction, requires further exploration of its pathomechanisms and therapeutic options. Hydroxysafflor Yellow A (HYSA), extracted from Carthamus tinctorius L, has shown anti-inflammatory and antioxidant properties effective in treating sepsis, though its precise mechanism remains unclear. In this study, a cecum ligation puncture (CLP) model was used to evaluate HYSA’s effects on sepsis-induced organ injury. HYSA (300 mg/kg) was administered intraperitoneally 4 h post-CLP. Results showed that HYSA inhibited the inflammatory response and improved pathological scores in the liver, lungs, and kidneys. Metabolomics analysis identified key metabolites and pathways influenced by HYSA, including nicotinate and nicotinamide metabolism and glycine/serine metabolism. Network pharmacology and molecular docking identified JAK2/STAT1 as potential targets, with Western blotting confirmed that HYSA inhibits JAK2/STAT1 phosphorylation. These findings suggest that HYSA protects against sepsis-induced organ injury by regulating metabolic networks and modulating the JAK2/STAT1 pathway.
format Article
id doaj-art-e16627d45d5f4d0a938a1a9c38dcdfd5
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-e16627d45d5f4d0a938a1a9c38dcdfd52025-08-20T03:46:08ZengNature PortfolioScientific Reports2045-23222025-07-0115111810.1038/s41598-025-11545-2Hydroxysafflor Yellow A modulation of metabolite networks and inhibition of JAK2/STAT1 pathway in sepsisBingbing Pan0Fengting Chen1Siyan Shen2Yu Jiang3Ying Yang4Jia Wang5Yanjuan Liu6Lai Wei7Jitong Liu8Gaoyin Kong9Xuan He10Bing Guo11Department of Anesthesiology, Clinical Research Center for Anesthesiology of ERAS in Hunan Province, Hunan Provincial People’s Hospital and The First Affiliated Hospital of Hunan Normal UniversityThe First Affiliated Hospital of Hunan Normal University (Hunan Provincial People’s Hospital)The First Affiliated Hospital of Hunan Normal University (Hunan Provincial People’s Hospital)Department of Emergency Medicine, Clinical Research Center For Emergency and Critical Care in Hunan Province, Hunan Provincial Key Laboratory of Emergency and Critical Care Metabonomics, Hunan Provincial Institute of Emergency Medicine, Hunan Provincial People’s Hospital and The First Affiliated Hospital of Hunan Normal UniversityDepartment of Anesthesiology, Clinical Research Center for Anesthesiology of ERAS in Hunan Province, Hunan Provincial People’s Hospital and The First Affiliated Hospital of Hunan Normal UniversityHunan Provincial Key Laboratory of Emergency and Critical Care Metabonomics, Hunan Provincial People’s Hospital and The First Affiliated Hospital of Hunan Normal UniversityDepartment of Emergency Medicine, Clinical Research Center For Emergency and Critical Care in Hunan Province, Hunan Provincial Key Laboratory of Emergency and Critical Care Metabonomics, Hunan Provincial Institute of Emergency Medicine, Hunan Provincial People’s Hospital and The First Affiliated Hospital of Hunan Normal UniversityDepartment of Anesthesiology, Clinical Research Center for Anesthesiology of ERAS in Hunan Province, Hunan Provincial People’s Hospital and The First Affiliated Hospital of Hunan Normal UniversityDepartment of Anesthesiology, Clinical Research Center for Anesthesiology of ERAS in Hunan Province, Hunan Provincial People’s Hospital and The First Affiliated Hospital of Hunan Normal UniversityDepartment of Anesthesiology, Clinical Research Center for Anesthesiology of ERAS in Hunan Province, Hunan Provincial People’s Hospital and The First Affiliated Hospital of Hunan Normal UniversityCollege of Traditional Chinese Medicine, Changsha Medical UniversityHunan University of Chinese MedicineAbstract Sepsis, a severe infectious disease causing multiple organ dysfunction, requires further exploration of its pathomechanisms and therapeutic options. Hydroxysafflor Yellow A (HYSA), extracted from Carthamus tinctorius L, has shown anti-inflammatory and antioxidant properties effective in treating sepsis, though its precise mechanism remains unclear. In this study, a cecum ligation puncture (CLP) model was used to evaluate HYSA’s effects on sepsis-induced organ injury. HYSA (300 mg/kg) was administered intraperitoneally 4 h post-CLP. Results showed that HYSA inhibited the inflammatory response and improved pathological scores in the liver, lungs, and kidneys. Metabolomics analysis identified key metabolites and pathways influenced by HYSA, including nicotinate and nicotinamide metabolism and glycine/serine metabolism. Network pharmacology and molecular docking identified JAK2/STAT1 as potential targets, with Western blotting confirmed that HYSA inhibits JAK2/STAT1 phosphorylation. These findings suggest that HYSA protects against sepsis-induced organ injury by regulating metabolic networks and modulating the JAK2/STAT1 pathway.https://doi.org/10.1038/s41598-025-11545-2Hydroxysafflor Yellow ASepsisMulti-organ damageMetabolomicsNetwork pharmacologyJAK2/STAT1
spellingShingle Bingbing Pan
Fengting Chen
Siyan Shen
Yu Jiang
Ying Yang
Jia Wang
Yanjuan Liu
Lai Wei
Jitong Liu
Gaoyin Kong
Xuan He
Bing Guo
Hydroxysafflor Yellow A modulation of metabolite networks and inhibition of JAK2/STAT1 pathway in sepsis
Scientific Reports
Hydroxysafflor Yellow A
Sepsis
Multi-organ damage
Metabolomics
Network pharmacology
JAK2/STAT1
title Hydroxysafflor Yellow A modulation of metabolite networks and inhibition of JAK2/STAT1 pathway in sepsis
title_full Hydroxysafflor Yellow A modulation of metabolite networks and inhibition of JAK2/STAT1 pathway in sepsis
title_fullStr Hydroxysafflor Yellow A modulation of metabolite networks and inhibition of JAK2/STAT1 pathway in sepsis
title_full_unstemmed Hydroxysafflor Yellow A modulation of metabolite networks and inhibition of JAK2/STAT1 pathway in sepsis
title_short Hydroxysafflor Yellow A modulation of metabolite networks and inhibition of JAK2/STAT1 pathway in sepsis
title_sort hydroxysafflor yellow a modulation of metabolite networks and inhibition of jak2 stat1 pathway in sepsis
topic Hydroxysafflor Yellow A
Sepsis
Multi-organ damage
Metabolomics
Network pharmacology
JAK2/STAT1
url https://doi.org/10.1038/s41598-025-11545-2
work_keys_str_mv AT bingbingpan hydroxysaffloryellowamodulationofmetabolitenetworksandinhibitionofjak2stat1pathwayinsepsis
AT fengtingchen hydroxysaffloryellowamodulationofmetabolitenetworksandinhibitionofjak2stat1pathwayinsepsis
AT siyanshen hydroxysaffloryellowamodulationofmetabolitenetworksandinhibitionofjak2stat1pathwayinsepsis
AT yujiang hydroxysaffloryellowamodulationofmetabolitenetworksandinhibitionofjak2stat1pathwayinsepsis
AT yingyang hydroxysaffloryellowamodulationofmetabolitenetworksandinhibitionofjak2stat1pathwayinsepsis
AT jiawang hydroxysaffloryellowamodulationofmetabolitenetworksandinhibitionofjak2stat1pathwayinsepsis
AT yanjuanliu hydroxysaffloryellowamodulationofmetabolitenetworksandinhibitionofjak2stat1pathwayinsepsis
AT laiwei hydroxysaffloryellowamodulationofmetabolitenetworksandinhibitionofjak2stat1pathwayinsepsis
AT jitongliu hydroxysaffloryellowamodulationofmetabolitenetworksandinhibitionofjak2stat1pathwayinsepsis
AT gaoyinkong hydroxysaffloryellowamodulationofmetabolitenetworksandinhibitionofjak2stat1pathwayinsepsis
AT xuanhe hydroxysaffloryellowamodulationofmetabolitenetworksandinhibitionofjak2stat1pathwayinsepsis
AT bingguo hydroxysaffloryellowamodulationofmetabolitenetworksandinhibitionofjak2stat1pathwayinsepsis